Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Open Forum Infectious Diseases|May 1, 2025
Serosurveillance to Support HPV Vaccination in EnglandKavita Panwar, Kazutomo Yokoya, Marta Checchi, et al.
Vaccine|September 24, 2011
Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine seraEve Draper, Sara L Bissett, Rebecca Howell-Jones, et al.
International Journal of Cancer|February 13, 2025
Scientific approaches to defining HPV vaccine-induced protective immunityMatti Lehtinen, Pierre van Damme, Simon Beddows, et al.
The Journal of Infectious Diseases|June 20, 2018
The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016David Mesher, Kavita Panwar, Sara L Thomas, et al.
Vaccine|February 4, 2022
Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix® or Gardasil® vaccineKavita Panwar, Anna Godi, Clementina E Cocuzza, et al.
Methodsx|July 11, 2022
Multiplex Human Papillomavirus L1L2 virus-like particle antibody binding assayKavita Panwar, Anna Godi, Clementina E Cocuzza, et al.
The Journal of Infectious Diseases|June 16, 2018
Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing AntibodiesAnna Godi, Marianna Martinelli, Mahmoud Haque, et al.
Vaccine|August 30, 2024
How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects?Adoración Navarro-Torné, Anja Anderson, Kavita Panwar, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2008
Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistanceAndrew J Buckton, Sara L Bissett, Richard E Myers, et al.
Sexually Transmitted Infections|December 17, 2020
Performance of human papillomavirus DNA detection in residual specimens taken for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoeae</i> nucleic acid amplification testing in men who have sex with menDiarmuid Nugent, Oliver Stirrup, Sarah Pett, et al.
Pageof 8